Correction to: Liquid biopsy epigenomic profiling for cancer subtyping (Nature Medicine, (2023), 29, 11, (2737-2741), 10.1038/s41591-023-02605-z)

Sylvan C. Baca, Ji Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H. ChauJames A. DeCaprio, William D. Figg, Tim F. Greten, Aaron N. Hata, F. Stephen Hodi, Melissa E. Hughes, Keith L. Ligon, Nancy Lin, Kimmie Ng, Matthew G. Oser, Catherine Meador, Heather A. Parsons, Mark M. Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M. Tolaney, Patrick Y. Wen, Henry Long, Jacob E. Berchuck, Zoltan Szallasi, Toni K. Choueiri, Matthew L. Freedman*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02605-z, published online 21 October 2023.

Original languageEnglish
Pages (from-to)907
Number of pages1
JournalNature Medicine
Volume30
Issue number3
DOIs
StatePublished - Mar 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Liquid biopsy epigenomic profiling for cancer subtyping (Nature Medicine, (2023), 29, 11, (2737-2741), 10.1038/s41591-023-02605-z)'. Together they form a unique fingerprint.

Cite this